Artificial Tears Market Size, Trends & Growth | Global Report Market Forecast to 2028 - Alcon Inc.; OASIS Medical; AbbVie Inc.; Bayer AG;

The artificial tears market was valued at US$ 2,612.91 million in 2020 and is projected to reach US$ 3,961.63 million by 2028; it is expected to grow at a CAGR of 5.5% from 2021 to 2028.
The major factors driving to the growth of the market are rising dry eye incidence and surging older population. However, poor accessibility to eye care services in low-income countries restrains the market growth. Artificial tears are lubricant eye drops used for treating the irritation and dryness associated with the deficiency in tear production in dry eyes or keratoconjunctivitis sicca. These are also used for moistening contact lenses and during eye checkups and examinations. Aging makes people more susceptible to eye conditions, such as dry eye, which propels the demand for artificial tears. Thus, the rapidly surging aging population is primarily contributing in the growth of the artificial tears market. Also, the increasing number of eye surgeries and post eye surgery management is boosting the market growth.
Europe is recording an exponential growth in the number of COVID-19 confirmed cases. Spain, Germany, France, Italy, and the UK are the most affected countries in the region. Amid pandemic, people in European countries are spending more time indoors by keeping the central heating and staring at an electronic screen for long time. Therefore, the incidence of dry eye syndrome in increasing in the pandemic. According to studies, one in every four persons in the UK (about 13 million adults) suffers from dry eye, a condition that causes red, itchy, and fatigued eyes. Eye strain, another eye issue that has become more widespread in line with an increase in time spent staring at screens, can exacerbate these symptoms.
Download sample Report Copy (With Covid-19 Impact) @ https://bit.ly/3x9L2v9
Johnson and Johnson Services, Inc.; Alcon Inc.; OASIS Medical; AbbVie Inc.; Bayer AG; Prestige Consumer Healthcare Inc.; Santen Pharmaceutical Co., Ltd.; Bausch Health Companies Inc.; Akorn, Incorporated; and Aurolab are among the leading companies operating in the market.
Based on type, the artificial tears market is segmented into cellulose derived tears, glycerin derived tears, oil-based emulsion tears, polythylene glycol-based tears, propylene glycol-based tears, and sodium hyaluronate based artificial tears. The glycerin derived tears segment held the largest share of the market in 2020 owing to their easy availability and ability to keep eyes moist for long time. Glycerin is a humectant, as well as a demulcent and lubricant. It also promotes the growth of epithelial cell and reduces the harmful effects of high osmolarity on the ocular surface. Povidone is a lipid that binds to the tear film's existing oil layer, thickening it and reducing evaporation. Further, the glycerin derived tears segment is expected to register the highest CAGR during 2021–2028.
The incidence of dry eye is rising among population, especially in developed nations. Dry eye is caused by multiple factors that result in discomfort, irritation, and visual disturbance. For instance, according to a study “National Health and Wellness Survey” conducted in the US in April 2020, ~16.4 million people were diagnosed with dry eye. The data also stated that the prevalence has gone up by 2.7% among the people of age 18−34 years. Additionally, the prevalence was 18.6% among older people. Based on sex, the percentage of prevalence was higher in women; it accounted for 8.8% than men with 4.5%. The dry eye incidence is higher among the population in the European and Asia Pacific regions. The Middle East & Africa also has an increasing prevalence of dry eye due surging aging population and environmental conditions. According to an article published in 2019 by the Department of Research, King Khaled Eye Specialist Hospital, Riyadh, Saudi Arabia, the incidence of dry eye is high among women. The increasing incidence of dry eye is leading to the rise in direct cost of treatment. According to Ocular Surgery News, the annual direct cost for mild dry eye symptom treatment was US$ 678, for moderate dry eye symptom was US$ 771, and for the severe dry eye symptom was US$ 1,267. Artificial tears drop provide moisture and relief for dry eyes. Thus, the increasing prevalence of dry eye is expected to drive the artificial tears market during the forecast period.
Artificial Tears Market– by Geography
• North America
o US
o Canada
o Mexico
• Europe
o France
o Germany
o Italy
o UK
o Spain
o Rest of Europe
• Asia Pacific (APAC)
o China
o India
o South Korea
o Japan
o Australia
o Rest of APAC
• Middle East and Africa (MEA)
o South Africa
o Saudi Arabia
o UAE
o Rest of MEA
• South and Central America (SCAM)
o Brazil
o Argentina
o Rest of SCAM

Major questions addressed through this global research report:
1. What are the demanding sectors for driving this global Artificial Tears market?
2. Which are the major key players and competitors?
3. What will be the market size of the global market?
4. Which are the recent advancements in the global Artificial Tears market?
5. What are the restraints, threats, and challenges in front of the market?
6. What are the global opportunities in front of the market?
7. How digital footprint helps to expand the business structure and economic outcomes?
Table of Content (TOC):
Chapter 1 Introduction and Overview
Chapter 2 Industry Cost Structure and Economic Impact
Chapter 3 Rising Trends and New Technologies with Major key players
Chapter 4 Global Artificial Tears Market Analysis, Trends, Growth Factor
Chapter 5 Artificial Tears Market Application and Business with Potential Analysis
Chapter 6 Global Artificial Tears Market Segment, Type, Application
Chapter 7 Global Artificial Tears Market Analysis (by Application, Type, End User)
Chapter 8 Major Key Vendors Analysis of Artificial Tears Market
Chapter 9 Development Trend of Analysis
Chapter 10 Conclusion

Purchase Full Copy of This Report @ https://bit.ly/3pxEAvy

Contact Us:
Call: +1-646-491-9876
Email: sales@theinsightpartners.com

About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense.

This release was published on openPR.